Skip to content

How robots are helping personalize knee replacement surgery

How robots are helping personalize knee replacement surgery
For Arthritis Awareness Month, learn the latest about this common procedure and how Johnson & Johnson MedTech is innovating to improve patient outcomes.

Table of Contents

Johnson & Johnson's VELYS Robotic-Assisted Solution for Knee Replacement Surgery - Innovative Medical Technology for Orthopaedic Surgery

Johnson & Johnson's VELYS Robotic-Assisted Solution is revolutionizing knee replacement surgery. With approximately 790,000 surgeries performed in the U.S. each year, the demand for knee replacements is only expected to grow. The most common reason for knee replacement is osteoarthritis, which causes pain as the protective cartilage in the knee breaks down.

Advances in technology have made knee replacement surgery more accessible, with joint implants becoming more durable. Johnson & Johnson's VELYS™ Robotic-Assisted Solution, in conjunction with the ATTUNE™ Knee System implants, is at the forefront of these advances. The company is working to expand the system for use in both total and partial knee replacement procedures.

Younger patients are now candidates for knee replacement surgery, with implants that can last up to 25 years. The popularity of cementless knee replacements is also on the rise, allowing for a better match with the patient's anatomy.

In robotic-assisted total knee replacement surgery, technology assists the surgeon in gathering personalized data about the patient's knee anatomy, providing precision and accuracy during surgical procedures.

The recovery time for knee replacement surgery has decreased in recent years, with some procedures even being done on an outpatient basis. Patients are encouraged to resume normal activities as soon as possible, with recovery times varying from a few weeks to several months.

Overall, Johnson & Johnson's VELYS Robotic-Assisted Solution is changing the landscape of knee replacement surgery, making it more accessible and effective for patients.

Source

Latest